Health and Healthcare

AstraZeneca : AZN

All AstraZeneca Articles

218 Articles

Chris Lange | Jul 26, 2020 at 6:31 AM EDT

AbbVie, Eli Lilly, Gilead, and More Biopharma Stocks Reporting Earnings This Week

Earnings season is in full swing, and we have put together a preview of some of the world’s largest players…

Chris Lange | Jul 3, 2020 at 7:33 AM EDT

5 FDA COVID-19 Decisions in July Could Make or Break Stocks

Here is a look of a few of the biggest clinical trial and FDA updates to watch for in July…

247sarah | May 8, 2020 at 2:02 PM EDT

Why an Appeals Court May Hold Key to Amarin Stock Future

Amarin Corp. PLC (NASDAQ: AMRN) plans to mount a vigorous and speedy appeal of a U.S. District Court ruling that…

Paul Ausick | Mar 31, 2020 at 1:17 PM EDT

Court Rejects Patent Protection, Crushing Amarin Stock

Until late Monday, Amarin continued to get good news relevant to Vascepa, its treatment for cardiovascular disease. The big news,…

Lee Jackson | Mar 31, 2020 at 7:05 AM EDT

Why Big Pharmaceutical Stocks May Be the Best Place for Worried Investors Now

Some investors are looking for conservative growth ideas, and big pharma may be the ticket. These four top stocks have…

Lee Jackson | Feb 11, 2020 at 7:15 AM EST

5 Big Dividend Pharmaceutical Stocks to Buy as Health Care Could Explode Higher

24/7 Wall St. screened the Merrill Lynch health care research database looking for large pharmaceutical leaders that also pay solid…

Jon C. Ogg | Jan 21, 2020 at 10:15 AM EST

FDA Fast Track on Lung Cancer Treatment Brings Exponential Gains for This Microcap Stock

When companies see their shares rise by 100% or more in a single day, it's usually because of a buyout…

Chris Lange | Dec 30, 2019 at 9:50 AM EST

AstraZeneca’s FDA Nod Could Be Big

AstraZeneca has announced that the FDA has approved its companion diagnostic test that identifies patients with metastatic pancreatic cancer.

Jon C. Ogg | Aug 14, 2019 at 9:05 AM EDT

Top Analyst Upgrades and Downgrades: Acorda, Activision, Bloom Energy, Care.com, CBS, Deere, Ferrari and More

The top analyst upgrades, downgrades and initiations for Wednesday included Acorda Therapeutics, Activision Blizzard, Bloom Energy, Care.com, CBS, Deere and…

Chris Lange | May 29, 2019 at 3:51 PM EDT

AstraZeneca Cuts Almost All Ties to Inovio Pharma

Inovio Pharmaceuticals shares dipped on Wednesday after it was announced that the firm’s partnership with AstraZeneca would be scaled back.

Jon C. Ogg | Apr 2, 2019 at 8:55 AM EDT

Top Analyst Upgrades and Downgrades: Alcoa, Broadcom, Disney, Dow, Lyft, Netflix, Roku, Wingstop, Xilinx and More

The top analyst upgrades, downgrades and initiations seen on Tuesday included Alcoa, Broadcom, Dow, Lyft, Netflix, Roku, Walt Disney, Wingstop…

Jon C. Ogg | Apr 1, 2019 at 8:50 AM EDT

Top Analyst Upgrades and Downgrades: Amazon, CarMax, Celgene, Chevron, Exxon, Lyft, FedEx, Peabody Energy, UPS, Wells Fargo and More

The top analyst upgrades, downgrades and initiations seen on Monday included Amazon.com, CarMax, Celgene, Chevron, Exxon Mobil, Lyft, FedEx, Peabody…

Trey Thoelcke | Feb 22, 2019 at 8:00 AM EST

Johnson & Johnson and Other Health Care Stocks With Recent Death Crosses

Here are five top health care stocks that recently saw their 50-day moving average cross below the 200-day average, a…

Chris Lange | Feb 8, 2019 at 8:40 AM EST

Major 2019 Biopharma Catalysts Coming in February and March

Here, 24/7 Wall St. has included a calendar of some of the biggest companies expecting clinical trial and U.S. Food…

Lee Jackson | Jan 25, 2019 at 9:10 AM EST

Top Analyst Upgrades and Downgrades: Avaya, AstraZeneca, HD Supply, HubSpot, Intel, Norfolk Southern, Ultimate Software, Valero Energy and More

The top analyst upgrades, downgrades and initiations seen on Friday included Avaya, AstraZeneca, HD Supply, HubSpot, Intel, Norfolk Southern, Ultimate…

1 … 3 4 5 6 7 … 15

AstraZeneca : AZN

All AstraZeneca Articles

AbbVie, Eli Lilly, Gilead, and More Biopharma Stocks Reporting Earnings This Week

5 FDA COVID-19 Decisions in July Could Make or Break Stocks

Why an Appeals Court May Hold Key to Amarin Stock Future

Court Rejects Patent Protection, Crushing Amarin Stock

Why Big Pharmaceutical Stocks May Be the Best Place for Worried Investors Now

5 Big Dividend Pharmaceutical Stocks to Buy as Health Care Could Explode Higher

FDA Fast Track on Lung Cancer Treatment Brings Exponential Gains for This Microcap Stock

AstraZeneca’s FDA Nod Could Be Big

Top Analyst Upgrades and Downgrades: Acorda, Activision, Bloom Energy, Care.com, CBS, Deere, Ferrari and More

AstraZeneca Cuts Almost All Ties to Inovio Pharma

Top Analyst Upgrades and Downgrades: Alcoa, Broadcom, Disney, Dow, Lyft, Netflix, Roku, Wingstop, Xilinx and More

Top Analyst Upgrades and Downgrades: Amazon, CarMax, Celgene, Chevron, Exxon, Lyft, FedEx, Peabody Energy, UPS, Wells Fargo and More

Johnson & Johnson and Other Health Care Stocks With Recent Death Crosses

Major 2019 Biopharma Catalysts Coming in February and March

Top Analyst Upgrades and Downgrades: Avaya, AstraZeneca, HD Supply, HubSpot, Intel, Norfolk Southern, Ultimate Software, Valero Energy and More

Jim Cramer to Brinker’s CEO: How Do You Make More Money When Every Cost Is Going the Wrong Way?

Retirees Are Realizing a $1.5 Million Nest Egg at 60 Only Means $31,000 in Real Annual Spending

Turning $250K Into $1M in 5 Years: Why This Real Estate Promise Is a Red Flag

Retirees Are Realizing a $1.5 Million Nest Egg at 60 Only Means $31,000 in Real Annual Spending

71% of Americans With Financial Advisors Feel Secure. Only 10% Without One Do

Jim Cramer to Brinker’s CEO: How Do You Make More Money When Every Cost Is Going the Wrong Way?

Retirees Are Realizing a $1.5 Million Nest Egg at 60 Only Means $31,000 in Real Annual Spending

AstraZeneca : AZN

All AstraZeneca Articles

AbbVie, Eli Lilly, Gilead, and More Biopharma Stocks Reporting Earnings This Week

5 FDA COVID-19 Decisions in July Could Make or Break Stocks

Why an Appeals Court May Hold Key to Amarin Stock Future

Court Rejects Patent Protection, Crushing Amarin Stock

Why Big Pharmaceutical Stocks May Be the Best Place for Worried Investors Now

5 Big Dividend Pharmaceutical Stocks to Buy as Health Care Could Explode Higher

FDA Fast Track on Lung Cancer Treatment Brings Exponential Gains for This Microcap Stock

AstraZeneca’s FDA Nod Could Be Big

Top Analyst Upgrades and Downgrades: Acorda, Activision, Bloom Energy, Care.com, CBS, Deere, Ferrari and More

AstraZeneca Cuts Almost All Ties to Inovio Pharma

Top Analyst Upgrades and Downgrades: Alcoa, Broadcom, Disney, Dow, Lyft, Netflix, Roku, Wingstop, Xilinx and More

Top Analyst Upgrades and Downgrades: Amazon, CarMax, Celgene, Chevron, Exxon, Lyft, FedEx, Peabody Energy, UPS, Wells Fargo and More

Johnson & Johnson and Other Health Care Stocks With Recent Death Crosses

Major 2019 Biopharma Catalysts Coming in February and March

Top Analyst Upgrades and Downgrades: Avaya, AstraZeneca, HD Supply, HubSpot, Intel, Norfolk Southern, Ultimate Software, Valero Energy and More

Jim Cramer to Brinker’s CEO: How Do You Make More Money When Every Cost Is Going the Wrong Way?

Retirees Are Realizing a $1.5 Million Nest Egg at 60 Only Means $31,000 in Real Annual Spending

Turning $250K Into $1M in 5 Years: Why This Real Estate Promise Is a Red Flag

Featured Reads

Retirees Are Realizing a $1.5 Million Nest Egg at 60 Only Means $31,000 in Real Annual Spending

71% of Americans With Financial Advisors Feel Secure. Only 10% Without One Do